Insights
FDA Inspection Readiness Checklist
For pharmaceutical and biopharma companies, FDA inspections are critical checkpoints in the journey toward regulatory approval. New Drug Applications (NDAs) require meticulous preparation to ensure
Guide to Fixing Common IDE Submission Issues
For medical device companies seeking to conduct clinical trials in the United States, an Investigational Device Exemption (IDE) application is essential. A well-prepared IDE submission
FDA IDE Review Timelines: How to Accelerate the Process
For medical device sponsors, timely Investigational Device Exemption (IDE) submission and approval is critical to initiating clinical trials and advancing product development. Delays in IDE
Data Integrity Readiness for FDA Inspections
Ensuring Compliance with Electronic QMS Solutions In the Pharmaceutical, Biotech, and Medical device industries, maintaining data integrity and traceability is critical for regulatory compliance and operational efficiency. BioBoston Consulting specializes in validated eQMS platforms, enabling life sciences
Preparing Pharma Quality Systems for FDA Inspection Success
QMS Inspection Readiness: Are You FDA-Prepared? An FDA inspection rarely fails because a company lacks procedures. It fails because the Quality Management System (QMS) does
Managing Regulatory risk across IND, BLA Lifecycles
Introduction Life sciences programs face evolving regulatory risks at every stage from preclinical IND filings to global CTA submissions, and through NDA or BLA approvals.